Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Mallinckrodt
Express Scripts
Baxter
Medtronic

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 9,403,873

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,403,873
Title:Peptides targeting receptor activator of nuclear factor-.kappa.B (RANK) and their applications
Abstract: The present invention relates to a polypeptide for use as a medicament in the treatment and/or prevention of a disease wherein the RANKL-RANK signaling pathway is involved, in particular a bone resorptive disease.
Inventor(s): Heymann; Dominique (Indre, FR), Teletchea; Stephane (Bouguenais, FR), Stresing; Verena (Nantes, FR)
Assignee: UNIVERSITE DE NANTES (Nantes, FR) Nantes; Chu (Nantes, FR)
Application Number:14/368,080
Patent Claims:see list of patent claims

Details for Patent 9,403,873

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Nps Pharmaceuticals, Inc. NATPARA parathyroid hormone For Injection 125511 2015-01-23 ⤷  Try it Free 2031-12-23
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Colorcon
McKesson
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.